Company Overview
Company Type: Private Company
Website: phenomic.ai
Number of Employees: -
Year Founded: 2017
Total Amount Raised (CAD mm)†: 9.97
Total Rounds of Funding**:2
Latest Post-Money Valuation ($ mm) -
Latest Pre-Money Valuation ($ mm) -
† This number reflects the estimated value of the total new money raised through private placement rounds.
** This value is an estimate of the total number of funding rounds this company has received.


Business Description
Phenomic AI Inc. develops artificial intelligence learning solutions for drug discovery and cancer treatment. The company was founded in 2017 and is headquartered in Toronto, Canada.


Financial Information (Currency: CAD, in mm)
Total Revenue
-
Operating Income
-
Total Assets
-
Gross Profit
-
EBITDA
-
Total Debt
-
Net Income
-
Estimated Number of Employees
-
Net Debt
-
* Hover over data point numbers for date and source.

Key Professionals
Name
Title
Cooper, Sam 
Co-Founder
Kraus, Oren 
Co-Founder
Jetha, Arif 
Chief Operating Officer
Briskin, Michael 
C.S.O & Chair of SAB

Key Board Members
Name
Title
Briskin, Michael 
C.S.O & Chair of SAB


Primary Industry Classification
Biotechnology


Primary Office Location
661 University Avenue Suite 1300 | Toronto, ON | M5G 0B7 | Canada

Current and Pending Investors
Investor
Initial Investment Date
Stake Type
Current Stake Amount
Round(s)
AV8 Ventures
Jun-30-2020
Minority
-
Seed
Cantos Ventures
Jun-30-2020
Unknown
-
Seed
CTI Life Sciences
Jun-30-2020
Minority
-
Seed
Garage Capital
Jun-30-2020
Unknown
-
Seed
Hike Ventures, LLC
Jun-30-2020
Unknown
-
Seed


Company Notes
No Company Notes exist.


Strategy Notes
No Strategy Notes exist.


Last 5 Transactions
Announced Date
Closed Date
Transaction Type
Role
Target
Buyer/Investors
Sellers
Size($mm)
Jun-30-2020
Oct-07-2020
Private Placement
Target
Phenomic AI Inc.
Cantos Ventures,CTI Life Sciences,Viva BioInnovator,AV8 Ventures,Luminous Ventures Limited,Garage Capital,Hike Ventures, LLC Buyer Funds:CTI Life Sciences Fund II

6.00
Jun-19-2018
Jun-19-2018
Private Placement
Target
Phenomic AI Inc.


1.51
* denotes that the relationship is proprietary


Last 5 Key Developments
Date
Event Type
Headline
Mar-20-2023
Company Conference Presentations
Phenomic AI Inc. Presents at Festival of Biologics World Antibody Congress USA, Mar-20-2023 through Mar-22-2023
Mar-01-2022
Company Conference Presentations
Phenomic AI Inc. Presents at Truist Securities AI Symposium-Biotech & Tools, Mar-01-2022
Oct-07-2020
Private Placements
Phenomic AI Inc. announced that it has received CAD 7.97 million in funding from a group of investors
Jun-30-2020
Private Placements
Phenomic AI Inc. announced that it expects to receive funding from CTI Life Sciences and other investors
Jan-08-2019
Company Conference Presentations
Phenomic AI Inc. Presents at Biotech Showcase 2019, Jan-08-2019 08:30 AM


Last 10 Investment Research Documents
Contributor
Analyst
Date/Time
Company
Headline
Type
Pages
GlobalData

Sep 14, 2023 09:25 PM
Phenomic AI Inc.
Phenomic AI Inc
Reports
33
GlobalData

Jun 15, 2023 11:29 PM
Phenomic AI Inc.
Phenomic AI Inc
Reports
33
GlobalData

Mar 15, 2023 03:09 AM
Phenomic AI Inc.
Phenomic AI Inc
Reports
33
GlobalData

Dec 14, 2022 03:54 AM
Phenomic AI Inc.
Phenomic AI Inc
Reports
33
GlobalData

Sep 19, 2022 05:27 AM
Phenomic AI Inc.
Phenomic AI Inc
Reports
33
GlobalData

Jun 15, 2022 04:01 AM
Phenomic AI Inc.
Phenomic AI Inc
Reports
33
GlobalData

Mar 17, 2022 05:13 AM
Phenomic AI Inc.
Phenomic AI Inc
Reports
33
GlobalData

Dec 15, 2021 02:26 AM
Phenomic AI Inc.
Phenomic AI Inc
Reports
30
GlobalData

Sep 19, 2021 02:25 AM
Phenomic AI Inc.
Phenomic AI Inc
Reports
19


S&P Global Ratings Credit Ratings
No S&P Global Ratings Credit Ratings data available. 


News Headlines
No News is currently available for the selected sources.


Company Coverage
This company is not on any Coverage List.

Key Board Members Details
Name
Title
Phone
Fax
Email
Briskin, Michael 
C.S.O & Chair of SAB
-
-

* denotes that the relationship is proprietary

Key Executives and Professionals Details
Name
Title
Phone
Fax
Email
Cooper, Sam 
Co-Founder
-
-

Kraus, Oren 
Co-Founder
-
-
-
Jetha, Arif 
Chief Operating Officer
-
-

Briskin, Michael 
C.S.O & Chair of SAB
-
-

* denotes that the relationship is proprietary

S&P Credit Ratings and Research provided by 
No content (including ratings, credit-related analyses and data, valuations, model, software or other application or output therefrom) or any part thereof (Content) may be modified, reverse engineered, reproduced or distributed in any form by any means, or stored in a database or retrieval system, without the prior written permission of S&P Global Market Intelligence or its affiliates (collectively, S&P Global). The Content shall not be used for any unlawful or unauthorized purposes. S&P Global and any third-party providers, as well as their directors, officers, shareholders, employees or agents (collectively S&P Global Parties) do not guarantee the accuracy, completeness, timeliness or availability of the Content. S&P Global Parties are not responsible for any errors or omissions (negligent or otherwise), regardless of the cause, for the results obtained from the use of the Content, or for the security or maintenance of any data input by the user. The Content is provided on an "as is" basis. S&P GLOBAL PARTIES DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, ANY WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE, FREEDOM FROM BUGS, SOFTWARE ERRORS OR DEFECTS, THAT THE CONTENT’S FUNCTIONING WILL BE UNINTERRUPTED OR THAT THE CONTENT WILL OPERATE WITH ANY SOFTWARE OR HARDWARE CONFIGURATION. In no event shall S&P Global Parties be liable to any party for any direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs, expenses, legal fees, or losses (including, without limitation, lost income or lost profits and opportunity costs or losses caused by negligence) in connection with any use of the Content even if advised of the possibility of such damages.

Credit-related and other analyses, including ratings, and statements in the Content are statements of opinion as of the date they are expressed and not statements of fact. S&P Global Market Intelligence’s opinions, analyses and rating acknowledgment decisions (described below) are not recommendations to purchase, hold, or sell any securities or to make any investment decisions, and do not address the suitability of any security. S&P Global Market Intelligence assumes no obligation to update the Content following publication in any form or format. The Content should not be relied on and is not a substitute for the skill, judgment and experience of the user, its management, employees, advisors and/or clients when making investment and other business decisions. S&P Global Market Intelligence does not act as a fiduciary or an investment advisor except where registered as such. While S&P Global Market Intelligence has obtained information from sources it believes to be reliable, S&P Global Market Intelligence does not perform an audit and undertakes no duty of due diligence or independent verification of any information it receives.

S&P Global keeps certain activities of its divisions separate from each other in order to preserve the independence and objectivity of their respective activities. As a result, certain divisions of S&P Global may have information that is not available to other S&P Global divisions. S&P Global has established policies and procedures to maintain the confidentiality of certain non-public information received in connection with each analytical process.

S&P Global Ratings does not contribute to or participate in the creation of credit scores generated by S&P Global Market Intelligence. Lowercase nomenclature is used to differentiate S&P Global Market Intelligence PD credit model scores from the credit ratings issued by S&P Global Ratings.

S&P Global may receive compensation for its ratings and certain analyses, normally from issuers or underwriters of securities or from obligors. S&P Global reserves the right to disseminate its opinions and analyses. S&P Global's public ratings and analyses are made available on its Web sites, www.standardandpoors.com (free of charge), and www.capitaliq.com (subscription), and may be distributed through other means, including via S&P Global publications and third-party redistributors. Additional information about our ratings fees is available at www.standardandpoors.com/usratingsfees.
Regulatory News Service data provided by 
